dm+d

441851004

Articles

Search Articles

Medicine Compliance Aid Stability

CholestagelNeon Healthcare Ltd

Neon Healthcare Ltd
Cholestagel
Tablets f/c 625mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture.
9 November 2022

Lactation Safety Information

Yes
-
No published evidence of safety
Not absorbed from the mother’s GI tract
Theoretical effects of colestryramine on maternal cholesterol levels and availability of fat soluble vitamins (A, D, E, K) from the mother have not been shown to present a clinical risk to a breastfed infant
18 March 2017